Company Officially Becomes Itself LLC in Drug Probe
Published Date: 5/19/2026
Notice
Summary
The U.S. International Trade Commission has approved updating the investigation papers to reflect that Ascendis Pharma changed its name to Ascendis Pharma, LLC. This affects companies involved in a patent dispute over certain drug products with C-type natriuretic peptide variants. No delays or extra costs are expected, so the investigation keeps moving forward smoothly.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13416 — Magnesia Carbon Bricks From China and Mexico; Institution of Five-Year Reviews
The U.S. is checking if special taxes on magnesia carbon bricks from China and Mexico should stay or go. This review affects importers, manufacturers, and anyone involved in these bricks, with a deadline to share info by July 31, 2026. The results could impact prices and trade rules, so keep an eye out!
2026-13415 — Seamless Refined Copper Pipe and Tube From Vietnam; Institution of a Five-Year Review
The U.S. is checking if it should keep extra taxes on seamless refined copper pipes and tubes from Vietnam. This review started July 1, 2026, and affects businesses that make or sell these pipes in the U.S. If the taxes go away, it might hurt American companies, so the government wants to hear from everyone by July 31, 2026.
2026-13436 — Polyvinyl Alcohol From China and Japan; Scheduling of Expedited Five-Year Reviews
The U.S. International Trade Commission is speeding up its review to decide if special taxes on polyvinyl alcohol from China and Japan should continue. This affects companies that make or sell this material in the U.S. The review started on June 5, 2026, and could impact prices and trade rules soon.
2026-13411 — Metal Lockers From China; Institution of Five-Year Reviews
The U.S. is checking if metal lockers from China still need special import taxes to protect American makers. If these taxes are removed, it could hurt local businesses. Companies and folks interested have until July 31, 2026, to share their thoughts, so the government can decide what’s best.
2026-13417 — Ironing Tables From China; Institution of a Five-Year Review
The U.S. is reviewing whether to keep tariffs on ironing tables from China to protect American makers from unfair pricing. If the tariffs are removed, it could hurt U.S. businesses that make these tables. People and companies have until July 31, 2026, to share their thoughts before a final decision is made.
2026-13435 — Certain Systems, Devices, Software, Compositions, Chemicals, and Laboratory Supplies for Studying Proteins; Notice of Institution of Investigation
The U.S. International Trade Commission is starting an investigation because Seer, Inc. and Brigham and Women's Hospital say some imported protein research tools are breaking their patents. This could lead to stopping those products from being sold in the U.S., affecting companies that make or sell these tools. The investigation kicks off now and could impact the market and money flow in this field soon.
Previous / Next Documents
Previous: 2026-10009 — Sunshine Act Meetings
The Unified Carrier Registration (UCR) Task Force is holding a public meeting on May 27, 2026, to discuss updates to the UCR Plan and Agreement that affect carriers who register for interstate transportation. They’ll review past meeting notes, consider changes, and set the stage for smoother registration processes. No new fees or costs are mentioned, but staying tuned is key for carriers and stakeholders.
Next: 2026-10012 — Advisory Committee on Immunization Practices (ACIP); Notice of Charter Re-Establishment
The CDC is officially bringing back the Advisory Committee on Immunization Practices (ACIP) for another two years after a paperwork mix-up caused a brief pause. This committee helps guide vaccine decisions that affect everyone’s health, so its return keeps important vaccine advice on track without extra costs or delays. The re-establishment shows the CDC’s commitment to keeping us safe and informed about immunizations.